Evidence map›Paper›PMID 35310803›Full record

ArticlePakistan journal of medical sciences2022

Clinical spectrum and outcomes of patients with different resistance patterns of

Fivzia Herekar, Samreen Sarfaraz, Muhammad Imran, Nida Ghouri, Saba Shahid, Marvi Mahesar

Open access · goldAbstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fivzia HerekarDr. Fivzia Herekar, FCPS, Indus Hospital and Health Network, Karachi, 75190, Pakistan.
Samreen SarfarazDr. Samreen Sarfaraz, FRCP, Indus Hospital and Health Network, Karachi, 75190, Pakistan.
Muhammad ImranDr. Muhammad Imran, PhD, Department of Pharmacy, Iqra University, Karachi, 71500, Pakistan.
Nida GhouriNida Ghouri, M.Phil, Indus Hospital and Health Network, Karachi, 75190, Pakistan.
Saba ShahidDr. Saba Shahid, FCPS, Indus Hospital and Health Network, Karachi, 75190, Pakistan.
Marvi MahesarDr. Marvi Mahesar, Indus Hospital and Health Network, Karachi, 75190, Pakistan.
Indus Hospital · PKIqra University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Unceasing rise in cases of enteric fever, in particular extensively drug resistant (XDR) strain of Salmonella enterica, has led to a growing threat, leaving only carbapenems and azithromycin as the precious option. In this regard, we determined the burden and clinical course of XDR salmonella in comparison to multidrug-resistant (MDR) and drug sensitive (DS) strains. Methods: A retrospective chart review of 1515 Salmonella Typhi (S.typhi) culture positive patients was conducted at Indus Hospital and Health Network, Karachi from July 2017 to December 2018. Results: During our study, we observed children at the age of 5-6 years and adults at the age of 20-22 years were the chief targets of S.typhi. Further, we witnessed a rapid shift of drug resistance from MDR to XDR over the one year of study. Almost all patients presented with fever. However other signs and symptoms like malaise, body aches, anorexia, diarrhea, vomiting and abdominal pain were more common in XDR Typhoid patients. Further, the need of hospitalization, total hospital stay and mortality was also greater for XDR typhoid patients. Conclusion: There is a crucial requirement for consolidated steps to curtail the spread of XDR Salmonella tyhi disease as its management is challenging, and it is associated with increased morbidity and mortality.

Indexed as

Clinical courseDrug sensitiveMDRS.typhiXDR

Identifiers

PMID35310803
PMCPMC8899895
OpenAlexW4200432512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.